The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959 · cited 2×
“In addition to the altered cell adhesion properties of tumour cells, the process of metastasis also involves the ability of these cells to remodel the extracellular matrix in the microenvironment of the tumour [151].”
BackgroundLXXIII.—Oxidation of tartaric acid in presence of iron
Fenton, H. J. H. (1894) · J. Chem. Soc., Trans. · doi:10.1039/ct8946500899 · Cited by 3,179
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166 · cited 10×
“The Fe(III) is reduced to Fe(II) by an endosomal ferrireductase known as the six-transmembrane epithelial antigen of the prostate 3 (Steap3) [46] and is then transported into the cytoplasm by DMT1 [24].”
BackgroundInfluentialThe ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
WISEMAN, H., & HALLIWELL, B. (1996) · Biochemical Journal · doi:10.1042/bj3130017 · Cited by 2,345
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914 · cited 2×
“The complex is formed upon translocation of HIF-1α into the nucleus, where it binds with HIF-1β which resides in the nucleus [101,126].”
BackgroundMethodHypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Oxidation of tartaric acid in presence of iron
Fenton, H. J. H. (1894) · Journal of the Chemical Society (Resumed) · Cited by 1,498
Hentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Iron-Chelating Therapy and the Treatment of Thalassemia
Olivieri, N. F., & Brittenham, G. M. (1997) · Blood · doi:10.1182/blood.v89.3.739 · Cited by 1,089
Vulpe, C. D., Kuo, Y.-M., Murphy, T. L., Cowley, L., Askwith, C., Libina, N., Gitschier, J., & Anderson, G. J. (1999) · Nature Genetics · doi:10.1038/5979 · Cited by 1,084
Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia
Levy, A. P., Levy, N. S., Wegner, S., & Goldberg, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13333 · Cited by 1,067
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Semenza, G. L., Nejfelt, M. K., Chi, S. M., & Antonarakis, S. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5680 · Cited by 990
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
Biologically relevant metal ion‐dependent hydroxyl radical generation An update
Halliwell, B., & Gutteridge, J. M. C. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80911-y · Cited by 883
O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., et al. (1997) · PubMed · Cited by 867
Qiu, A., Jansen, M., Sakaris, A., Min, S. H., Chattopadhyay, S., Tsai, E., Sandoval, C., Zhao, R., Akabas, M. H., & Goldman, I. D. (2006) · Cell · doi:10.1016/j.cell.2006.09.041 · Cited by 847
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
Ellwood-Yen, K., Graeber, T. G., Wongvipat, J., Iruela-Arispe, M. L., Zhang, J., Matusik, R., Thomas, G. V., & Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00197-1 · Cited by 816
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
Feldser, D. M., Agani, F. H., Iyer, N. V., Pak, B. J., Ferreira, G., & Semenza, G. L. (1999) · PubMed · Cited by 782
Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., Sharp, J. J., Fujiwara, Y., Barker, J. E., & Fleming, M. D. (2005) · Nature Genetics · doi:10.1038/ng1658 · Cited by 775
Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia
Bruick, R. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9082 · Cited by 773
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756 · cited 2×
“Thus, low serum Fe results in greater FPN1 expression and high serum Fe causes low FPN1 expression as a result of FPN1 internalisation [37].”
BackgroundIdentification of an Intestinal Heme Transporter
Shayeghi, M., Latunde-Dada, G. O., Oakhill, J. S., Laftah, A. H., Takeuchi, K., Halliday, N., Khan, Y., Warley, A., McCann, F. E., Hider, R. C., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.025 · Cited by 755 · cited 1×
“The body also obtains Fe from dietary haem with a putative transporter known as haem carrier protein 1 (HCP1) that was recently identified in the apical membrane of duodenal enterocytes [28,29].”
BackgroundRegulation of matrix metalloproteinase gene expression
Yan, C., & Boyd, D. D. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20948 · Cited by 754
The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer
Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721
Self-citationThe molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
Richardson, D. R., & Ponka, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/s0304-4157(96)00014-7 · Cited by 704
Self-citationSutherland, R., Delia, D., Schneider, C., Newman, R., Kemshead, J., & Greaves, M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4515 · Cited by 685
Jordan, A., & Reichard, P. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.71 · Cited by 670
I RON R EGULATORY P ROTEINS AND THE M OLECULAR C ONTROL OF M AMMALIAN I RON M ETABOLISM
Eisenstein, R. S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.627 · Cited by 653
Molecular Cloning of Transferrin Receptor 2
Kawabata, H., Yang, R., Hirama, T., Vuong, P. T., Kawano, S., Gombart, A. F., & Koeffler, H. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20826 · Cited by 650
Lebrón, J. A., Bennett, M. J., Vaughn, D. E., Chirino, A. J., Snow, P. M., Mintier, G. A., Feder, J. N., & Bjorkman, P. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81151-4 · Cited by 638
Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 634
(2003) · PubMed · Cited by 624
Binding of apotransferrin to K562 cells: explanation of the transferrin cycle.
Klausner, R. D., Ashwell, G., van Renswoude, J., Harford, J. B., & Bridges, K. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.8.2263 · Cited by 605
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Transferrin receptor is necessary for development of erythrocytes and the nervous system
Levy, J. E., Jin, O., Fujiwara, Y., Kuo, F., & Andrews, N. (1999) · Nature Genetics · doi:10.1038/7727 · Cited by 574
Structure of the human transferrin receptor-transferrin complex
Cheng, Y., Zak, O., Aisen, P., Harrison, S. C., & Walz, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00130-8 · Cited by 571
Receptor-mediated endocytosis of transferrin in K562 cells.
Klausner, R. D., Van Renswoude, J., Ashwell, G., Kempf, C., Schechter, A. N., Dean, A., & Bridges, K. R. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32481-5 · Cited by 564
Identification of an angiogenic mitogen selective for endocrine gland endothelium
LeCouter, J., Kowalski, J., Foster, J., Hass, P., Zhang, Z., Dillard-Telm, L., Frantz, G., Rangell, L., DeGuzman, L., Keller, G.-A., et al. (2001) · Nature · doi:10.1038/35091000 · Cited by 555
The Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
Arredondo, M., & Núñez, M. T. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.010 · Cited by 550
Free radical-lipid interactions and their pathological consequences
Rice-Evans, C., & Burdon, R. (1993) · Progress in Lipid Research · doi:10.1016/0163-7827(93)90006-i · Cited by 514
Whitnall, M., Howard, J., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604979103 · Cited by 509
Self-citationKnutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., & Wessling-Resnick, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409409102 · Cited by 479
Iron-induced carcinogenesis: The role of redox regulation
Toyokuni, S. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02111-6 · Cited by 471
The role of iron in cell cycle progression and the proliferation of neoplastic cells
Le, N. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00068-9 · Cited by 453
Mammalian Oxygen Sensing, Signalling and Gene Regulation
Wenger, R. H. (2000) · Journal of Experimental Biology · doi:10.1242/jeb.203.8.1253 · Cited by 453
E-cadherin—catenin cell—cell adhesion complex and human cancer
Wijnhoven, B. P. L., Dinjens, W. N. M., & Pignatelli, M. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01513.x · Cited by 451
Huang, X. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.023 · Cited by 444
Structure, function, and mechanism of ribonucleotide reductases
Kolberg, M., Strand, K. R., Graff, P., & Andersson, K. K. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.02.007 · Cited by 437
Iron uptake and metabolism in the new millennium
Dunn, L. L., Rahmanto, Y. S., & Richardson, D. R. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.12.003 · Cited by 420
Self-citationOxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1
Rolfs, A., Kvietikova, I., Gassmann, M., & Wenger, R. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20055 · Cited by 401
Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H., & Poellinger, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.402-415.2000 · Cited by 385
Richardson, D. R., Sharpe, P. C., Lovejoy, D. B., Senaratne, D., Kalinowski, D. S., Islam, M., & Bernhardt, P. V. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0606342 · Cited by 383
Self-citationYuan, J., Lovejoy, D. B., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-03-0868 · Cited by 381
Self-citationIdentification of a hypoxia response element in the transferrin receptor gene
Lok, C. N., & Ponka, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24147 · Cited by 380
Tse, J. C., & Kalluri, R. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21215 · Cited by 370
Finch, R. A., Liu, M.-C., Grill, S. P., Rose, W. C., Loomis, R., Vasquez, K. M., Cheng, Y.-C., & Sartorelli, A. C. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00419-0 · Cited by 366
Modulation of cell surface iron transferrin receptors by cellular density and state of activation
Larrick, J. W., & Cresswell, P. (1979) · Journal of Supramolecular Structure · doi:10.1002/jss.400110415 · Cited by 357
Richardson, D., Tran, E., & Ponka, P. (1995) · Blood · doi:10.1182/blood.v86.11.4295.bloodjournal86114295 · Cited by 345
Self-citationKARIHTALA, P., & SOINI, Y. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_514.x · Cited by 339
Trowbridge, I. S., & Lopez, F. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1175 · Cited by 328
Coordinated Regulation of Iron-Controlling Genes, H-Ferritin and IRP2 , by c-MYC
Wu, K.-J., Polack, A., & Dalla-Favera, R. (1999) · Science · doi:10.1126/science.283.5402.676 · Cited by 326
Le, N. T. V., & Richardson, D. R. (2004) · Blood · doi:10.1182/blood-2004-05-1866 · Cited by 321
Self-citationRibonucleotide Reductase and Cell Proliferation
Elford, H. L., Freese, M., Passamani, E., & Morris, H. P. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62745-0 · Cited by 312
de Leeuw, W. J. F., Berx, G., Vos, C. B. J., Peterse, J. L., Van de Vijver, M. J., Litvinov, S., Van Roy, F., Cornelisse, C. J., & Cleton-Jansen, A.-M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199712)183:4<404::aid-path1148>3.0.co;2-9 · Cited by 306
Iron-dependent regulation of the divalent metal ion transporter
Gunshin, H., Allerson, C. R., Polycarpou-Schwarz, M., Rofts, A., Rogers, J. T., Kishi, F., Hentze, M. W., Rouault, T. A., Andrews, N. C., & Hediger, M. A. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03189-1 · Cited by 305
Anticancer Antifolates: Current Status and Future Directions
McGuire, J. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033453712 · Cited by 305
Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma
Johnson, J. P. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006304806799 · Cited by 294
Iron Regulates the Intracellular Degradation of Iron Regulatory Protein 2 by the Proteasome
Guo, B., Phillips, J. D., Yu, Y., & Leibold, E. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21645 · Cited by 288
Iron trafficking in the mitochondrion: novel pathways revealed by disease
Napier, I., Ponka, P., & Richardson, D. R. (2005) · Blood · doi:10.1182/blood-2004-10-3856 · Cited by 288
Self-citationMolecular control of vertebrate iron homeostasis by iron regulatory proteins
Wallander, M. L., Leibold, E. A., & Eisenstein, R. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.004 · Cited by 287
Ribonucleotide Reductase Inhibitors and Future Drug Design
Shao, J., Zhou, B., Chu, B., & Yen, Y. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777723949 · Cited by 284
Metastasis-Suppressor Genes: a Review and Perspective on an Emerging Field
Yoshida, B. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.21.1717 · Cited by 273
Study of matrix metalloproteinases and their inhibitors in breast cancer
Vizoso, F. J., González, L. O., Corte, M. D., Rodríguez, J. C., Vázquez, J., Lamelas, M. L., Junquera, S., Merino, A. M., & García-Muñiz, J. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603666 · Cited by 271
Direct interorganellar transfer of iron from endosome to mitochondrion
Sheftel, A. D., Zhang, A.-S., Brown, C., Shirihai, O. S., & Ponka, P. (2007) · Blood · doi:10.1182/blood-2007-01-068148 · Cited by 271
Steps in tumor metastasis: new concepts from intravital videomicroscopy
Chambers, A. F., MacDonald, I. C., Schmidt, E. E., Koop, S., Morris, V. L., Khokha, R., & Groom, A. C. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690599 · Cited by 265
Hypoxia-inducible Factor 1 Transactivates the Human Leptin Gene Promoter
Grosfeld, A., André, J., Hauguel-de Mouzon, S., Berra, E., Pouysségur, J., & Guerre-Millo, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206775200 · Cited by 263
Hepcidin and Its Role in Regulating Systemic Iron Metabolism
Ganz, T. (2006) · Hematology · doi:10.1182/asheducation-2006.1.29 · Cited by 259
Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis
O'Donnell, K. A., Yu, D., Zeller, K. I., Kim, J.-W., Racke, F., Thomas-Tikhonenko, A., & Dang, C. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2373-2386.2006 · Cited by 253
Transferrin Receptor 2-α Supports Cell Growth Both in Iron-chelated Cultured Cells and in Vivo
Kawabata, H., Germain, R. S., Vuong, P. T., Nakamaki, T., Said, J. W., & Koeffler, H. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908846199 · Cited by 246
The Role of Iron Chelation in Cancer Therapy
Buss, J., Torti, F., & Torti, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457638 · Cited by 235
A ribonucleotide reductase gene is a transcriptional target of p53 and p73
Nakano, K., Bálint, É., Ashcroft, M., & Vousden, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203774 · Cited by 233
Tuning Cell Cycle Regulation with an Iron Key
Yu, Y., Kovacevic, Z., & Richardson, D. R. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4603 · Cited by 232
Self-citationCormier-Regard, S., Nguyen, S. V., & Claycomb, W. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17787 · Cited by 230
Modulation of iron transport proteins in human colorectal carcinogenesis
Brookes, M. J., Hughes, S., Turner, F. E., Reynolds, G., Sharma, N., Ismail, T., Berx, G., McKie, A. T., Hotchin, N., Anderson, G. J., et al. (2006) · Gut · doi:10.1136/gut.2006.094060 · Cited by 226
Gao, J., & Richardson, D. R. (2001) · Blood · doi:10.1182/blood.v98.3.842 · Cited by 224
Self-citationThe kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes.
Iacopetta, B. J., & Morgan, E. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44637-0 · Cited by 223
Kalinowski, D. S., Yu, Sharpe, P. C., Islam, M., Liao, Y.-T., Lovejoy, D. B., Kumar, N., Bernhardt, P. V., & Richardson, D. R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070445z · Cited by 222
Self-citationChaston, T. B., Lovejoy, D. B., Watts, R., & Richardson, D. R. (2003) · PubMed · Cited by 221
Self-citationEllen, T. P., Ke, Q., Zhang, P., & Costa, M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm200 · Cited by 220
Towards a mechanistic understanding of tumor invasion—lessons from theα 6 β 4integrin
Mercurio, A. M., & Rabinovitz, I. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0364 · Cited by 216
The iron metabolism of neoplastic cells: Alterations that facilitate proliferation?
Kwok, J. C., & Richardson, D. R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00213-x · Cited by 215
Hsu, M.-Y., Shih, D.-T., Meier, F. E., Van Belle, P., Hsu, J.-Y., Elder, D. E., Buck, C. A., & Herlyn, M. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65730-6 · Cited by 208
Roy, C. N., Penny, D. M., Feder, J. N., & Enns, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9022 · Cited by 206
Molecular mechanisms involved in intestinal iron absorption
Sharp, P. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4716 · Cited by 205 · cited 1×
“Two separate pathways facilitate the absorption of haem and non-haem Fe by enterocytes in the duodenum of the small intestine [17].”
BackgroundRichardson, D. R., & Milnes, K. (1997) · Blood · doi:10.1182/blood.v89.8.3025 · Cited by 205
Self-citationTP53: a key gene in human cancer
Guimaraes, D. P., & Hainaut, P. (2002) · Biochimie · doi:10.1016/s0300-9084(01)01356-6 · Cited by 203
Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators.
Nyholm, S., Mann, G. J., Johansson, A. G., Bergeron, R. J., Gräslund, A., & Thelander, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74300-2 · Cited by 199
Iron Chelators in Cancer Chemotherapy
Buss, J. L., Greene, B. T., Turner, J., Torti, F. M., & Torti, S. V. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387269 · Cited by 199
Brenneisen, P., Briviba, K., Wlaschek, M., Wenk, J., & Scharffetter-Kochanek, K. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00404-2 · Cited by 198
Effects of a single course of deferoxamine in neuroblastoma patients.
Donfrancesco, A., Deb, G., Dominici, C., Pileggi, D., Castello, M. A., & Helson, L. (1990) · PubMed · Cited by 196
Chelators at the cancer coalface: Desferrioxamine to Triapine and beyond
Yu, Y., Wong, J., Lovejoy, D. B., Kalinowski, D. S., & Richardson, D. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1954 · Cited by 195
Self-citationLowe, S. W. (1995) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199511000-00013 · Cited by 194
The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer
Kovacevic, Z., & Richardson, D. R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl146 · Cited by 193
Self-citation(1979) · FEBS Letters · doi:10.1016/0014-5793(79)80111-8 · Cited by 190
HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation
Bianchi, L., Tacchini, L., & Cairo, G. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.21.4223 · Cited by 189
Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice
Gunshin, H., Starr, C. N., DiRenzo, C., Fleming, M. D., Jin, J., Greer, E. L., Sellers, V. M., Galica, S. M., & Andrews, N. C. (2005) · Blood · doi:10.1182/blood-2005-02-0716 · Cited by 188 · cited 3×
“The uptake of Fe(III) from the gut is thought to require the activity of the ferrireductase, Dcytb, which catalyses the conversion of Fe(III) to Fe(II) [18].”
BackgroundIn vitro and in vivo effects of deferoxamine in neonatal acute leukemia
Estrov, Z., Tawa, A., Wang, X., Dube, I., Sulh, H., Cohen, A., Gelfand, E., & Freedman, M. (1987) · Blood · doi:10.1182/blood.v69.3.757.757 · Cited by 187
Poňka, P., Borová, J., Neuwirt, J., Fuchs, O., & Nečas, E. (1979) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(79)90100-4 · Cited by 183
The uptake of iron and transferrin by the human malignant melanoma cell
Richardson, D. R., & Baker, E. (1990) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(90)90018-9 · Cited by 179
Self-citationCooper, C. E., Lynagh, G. R., Hoyes, K. P., Hider, R. C., Cammack, R., & Porter, J. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20291 · Cited by 176
Shao, J., Zhou, B., Di Bilio, A. J., Zhu, L., Wang, T., Qi, C., Shih, J., & Yen, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0384 · Cited by 174
Glinskii, O. V., Huxley, V. H., Glinsky, G. V., Pienta, K. J., Raz, A., & Glinsky, V. V. (2005) · Neoplasia · doi:10.1593/neo.04646 · Cited by 170
Semenza, G. L. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9058-y · Cited by 169
Lovejoy, D. B., & Richardson, D. R. (2002) · Blood · doi:10.1182/blood.v100.2.666 · Cited by 168
Self-citationDarnell, G., & Richardson, D. R. (1999) · Blood · doi:10.1182/blood.v94.2.781 · Cited by 167
Self-citationIron and carcinogenesis: from Fenton reaction to target genes
Toyokuni, S. (2002) · Redox Report · doi:10.1179/135100002125000596 · Cited by 166
Marcus, D. M., & Zinberg, N. (1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/55.4.791 · Cited by 164
Transferrin receptors and iron uptake during erythroid cell development
Iacopetta, B. J., Morgan, E. H., & Yeoh, G. C. T. (1982) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(82)90547-8 · Cited by 160
Targeting Cell Cycle Kinases for Cancer Therapy
de Cárcer, G., de Castro, I. P., & Malumbres, M. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780362925 · Cited by 156
Knox, J. J., Hotte, S. J., Kollmannsberger, C., Winquist, E., Fisher, B., & Eisenhauer, E. A. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9044-9 · Cited by 153
Nurtjahja-Tjendraputra, E., Fu, D., Phang, J. M., & Richardson, D. R. (2006) · Blood · doi:10.1182/blood-2006-10-047753 · Cited by 153
Self-citationChromosomal aberrations and gene expression profiles in non-small cell lung cancer
Dehan, E., Ben‐Dor, A., Liao, W., Lipson, D., Frimer, H., Rienstein, S., Simansky, D. A., Krupsky, M., Yaron, P., Friedman, E., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.12.010 · Cited by 150
Antineuroblastoma activity of desferoxamine in human cell lines.
Blatt, J., & Stitely, S. (1987) · PubMed · Cited by 147
Kalinowski, D. S., & Richardson, D. R. (2007) · Chemical Research in Toxicology · doi:10.1021/tx700039c · Cited by 145 · cited 7×
“In contrast, Fe-depletionmediated by the chelator, 2,2- dipyridyl, was found to cause a 3-fold elevation in MMP-9 protein expression in HT1080 human fibrosarcoma cells [159].”
BackgroundInfluentialSelf-citationRichardson, D. R., & Bernhardt, P. V. (1999) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750050312 · Cited by 144
Self-citationMims, M. P., & Prchal, J. T. (2005) · Hematology · doi:10.1080/10245330500093419 · Cited by 142
Wadler, S., Makower, D., Clairmont, C., Lambert, P., Fehn, K., & Sznol, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.158 · Cited by 140
Fu, D., & Richardson, D. R. (2007) · Blood · doi:10.1182/blood-2007-03-076737 · Cited by 138
Self-citationTargeted Disruption of the Hepatic Transferrin Receptor 2 Gene in Mice Leads to Iron Overload
Wallace, D. F., Summerville, L., & Subramaniam, V. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.028 · Cited by 136
Serum ferritin as a guide to therapy in neuroblastoma.
HANN, H.-W. L., Levy, H. M., & Evans, A. E. (1980) · PubMed · Cited by 135
Baker, E., Richardson, D. R., Gross, S., & Ponka, P. (1992) · Hepatology · doi:10.1002/hep.1840150323 · Cited by 130
Self-citationNUTRIENT REGULATION OF CELL CYCLE PROGRESSION
Bohnsack, B. L., & Hirschi, K. K. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.011702.073203 · Cited by 130
Agarwal, D., Steve Goodison, B., Nicholson, B., Tarin, D., & Urquidi, V. (2003) · Differentiation · doi:10.1046/j.1432-0436.2003.710202.x · Cited by 129
Chaston, T. B., Watts, R., Yuan, J. J., & Richardson, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0865 · Cited by 129
Self-citationHO, T., Chen, S., Yang, Y., Liao, C., CHENG, H., & TSAO, Y. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.06.032 · Cited by 128
Richardson, D. R. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774462996 · Cited by 125
Self-citationDayani, P. N., Bishop, M. C., Black, K., & Zeltzer, P. M. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000024238.21349.37 · Cited by 114 · cited 1×
“The high TfR1 expression in tumour cells can probably be explained, at least in part, by the requirement for Fe by RR [97,98].”
BackgroundThe function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis
Dunn, L., Sekyere, E. O., Rahmanto, Y. S., & Richardson, D. R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl045 · Cited by 113
Self-citationTumor Cell Cytotoxicity of a Novel Metal Chelator
Torti, S. V., Torti, F. M., Whitman, S. P., Brechbiel, M. W., Park, G., & Planalp, R. P. (1998) · Blood · doi:10.1182/blood.v92.4.1384 · Cited by 111
Snapshots of the Reaction Mechanism of Matrix Metalloproteinases
Bertini, I., Calderone, V., Fragai, M., Luchinat, C., Maletta, M., & Yeo, K. J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200603100 · Cited by 109
Wallace, D. F., & Subramaniam, V.-N. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i35.4690 · Cited by 107
Zoller, H., Theurl, I., Koch, R., Kaser, A., & Weiss, G. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0587 · Cited by 106
Becker, E., Lovejoy, D. B., Greer, J. M., Watts, R., & Richardson, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705089 · Cited by 105
Self-citationTrinder, D., Zak, O., & Aisen, P. (1996) · Hepatology · doi:10.1053/jhep.1996.v23.pm0008675172 · Cited by 104
Deferoxamine inhibition of human neuroblastoma viability and proliferation.
Becton, D. L., & Bryles, P. (1988) · PubMed · Cited by 103
7 The Chemistry and Biological Activity of α -(N)-Heterocyclic Carboxaldehyde Thiosemicarbazones
Agrawal, K., & Sartorelli, A. C. (1978) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70259-5 · Cited by 101
Kalinowski, D. S., Sharpe, P. C., Bernhardt, P. V., & Richardson, D. R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070839q · Cited by 98
Self-citationBernhardt, P. V., Caldwell, L. M., Chaston, T. B., Chin, P., & Richardson, D. R. (2003) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-003-0486-z · Cited by 96
Self-citationAntholine, W. E., Knight, J. M., Whelan, H. T., & Petering, D. H. (1977) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11190-5 · Cited by 96
Shao, J., Zhou, B., Zhu, L., Qiu, W., Yuan, Y., Xi, B., & Yen, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3048 · Cited by 95
Role of nucleolin in posttranscriptional control of MMP-9 expression
Fähling, M., Steege, A., Perlewitz, A., Nafz, B., Mrowka, R., Persson, P. B., & Thiele, B. J. (2005) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2005.08.005 · Cited by 93
Effective Iron Chelation following Oral Administration of an Isoniazid‐Pyridoxal Hydrazone
Hoy, T. G., Humphrys, J., Jacobs, A. J., Williams, A., & Poňka, P. (1979) · British Journal of Haematology · doi:10.1111/j.1365-2141.1979.tb03771.x · Cited by 89
Green, D. A., Antholine, W. E., Wong, S. J., Richardson, D. R., & Chitambar, C. R. (2001) · PubMed · Cited by 89
Self-citationSerum and tumour ferritins in primary liver cancer.
Kew, M. C., Torrance, J. D., Derman, D. P., Simon, M., MACNAB, G. M., Charlton, R. W., & Bothwell, T. H. (1978) · Gut · doi:10.1136/gut.19.4.294 · Cited by 88
Liang, S. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg116 · Cited by 88
Sartorelli, A. C., Agrawal, K. C., & Moore, E. C. (1971) · Biochemical Pharmacology · doi:10.1016/0006-2952(71)90116-x · Cited by 86
MacKenzie, M. J., Saltman, D. L., Hirte, H. W., Low, J. A., Johnson, C., Pond, G. R., & Moore, M. J. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9066-3 · Cited by 85
Richardson, D. R., & Baker, E. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610119 · Cited by 84
Self-citationp53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator
Abeysinghe, R. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1607 · Cited by 83
Daar, S., & Pathare, A. V. (2006) · Annals of Hematology · doi:10.1007/s00277-005-0075-z · Cited by 83
Novel Roles for Iron Regulatory Proteins in the Adaptive Response to Iron Deficiency
Eisenstein, R. S., & Ross, K. L. (2003) · Journal of Nutrition · doi:10.1093/jn/133.5.1510s · Cited by 82
Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies
Tsimberidou, A. M., Alvarado, Y., & Giles, F. J. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.4.437 · Cited by 79
The uptake of inorganic iron complexes by human melanoma cells
Richardson, D. R., & Baker, E. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90133-i · Cited by 78
Self-citationFargion, S., Fracanzani, A. L., Brando, B., Arosio, P., Levi, S., & Fiorelli, G. (1991) · Blood · doi:10.1182/blood.v78.4.1056.1056 · Cited by 78
Han, O., & Kim, E. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21392 · Cited by 77
Haem carrier protein 1 (HCP1): Expression and functional studies in cultured cells
Latunde-Dada, G. O., Takeuchi, K., Simpson, R. J., & McKie, A. T. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.048 · Cited by 77
Hershko, C., AVRAMOVICI‐GRISARU, S., Link, G., GELFAND, L. S., & Sarel, S. (1981) · PubMed · Cited by 76
Zhang, W., & Frei, B. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01375-8 · Cited by 76
Hepcidin: an important new regulator of iron homeostasis
Hugman, A. (2006) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2006.00768.x · Cited by 76
Gojo, I., Tidwell, M. L., Greer, J. M., Takebe, N., Seiter, K. P., Pochron, M. F., Johnson, B. L., Sznol, M., & Karp, J. E. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.01.004 · Cited by 74
Distribution of ferritin receptors and coated pits on giant HeLa cells.
Bretscher, M. S., & Thomson, J. N. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01469.x · Cited by 73
Ponka, P., Richardson, D. R., Baker, E., Schulman, H. M., & Edward, J. T. (1988) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(88)90197-3 · Cited by 72
Self-citationIron nutrition in the UK: getting the balance right
Fairweather‐Tait, S. J. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2004394 · Cited by 72
Zhang, P., Tchou-Wong, K.-M., & Costa, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1525 · Cited by 72
Deferoxamine in children with recurrent neuroblastoma.
Blatt, J. (1994) · PubMed · Cited by 70
Chaston, T. B., & Richardson, D. R. (2003) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-002-0434-3 · Cited by 70
Self-citationDonfrancesco, A., Bernardi, B. D., Carli, M., Mancini, A., Nigro, M. A., Sio, L. D., Casale, F., Bagnulo, S., Helson, L., & Deb, G. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00068-t · Cited by 70
Iron chelation by pyridoxal isonicotinoyl hydrazone and analogues in hepatocytes in culture
Baker, E., Vitolo, M. L., & Webb, J. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90142-x · Cited by 67
Rahmanto, Y. S., Dunn, L., & Richardson, D. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210442 · Cited by 66
Self-citationCallapina, M., Zhou, J., Schnitzer, S. E., Metzen, E., Lohr, C., Deitmer, J. W., & Brüne, B. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.02.018 · Cited by 66
Kaomongkolgit, R., Cheepsunthorn, P., Pavasant, P., & Sanchavanakit, N. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.08.005 · Cited by 65
Up-regulation of vascular endothelial growth factor production by iron chelators.
Beerepoot, L. V., Shima, D. T., Kuroki, M., Yeo, K. T., & Voest, E. E. (1996) · PubMed · Cited by 60
Brekelmans, P., van Soest, P., Leenen, P. J. M., & van Ewijk, W. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241147 · Cited by 59
The release of iron and transferrin from the human melanoma cell
Richardson, D. R., & Baker, E. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90192-z · Cited by 56
Self-citationRichardson, D. R., & Ponka, P. (1994) · PubMed · Cited by 54
Self-citationRole of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator
Zhao, R., Planalp, R. P., Ma, R., Greene, B. T., Jones, B. T., Brechbiel, M. W., Torti, F. M., & Torti, S. V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.036 · Cited by 53
Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts.
Selig, R. A., White, L. E., Gramacho, C. M., Sterling-Levis, K., Fraser, I. W., & Naidoo, D. (1998) · PubMed · Cited by 53
Chantrel-Groussard, K., Gaboriau, F., Pasdeloup, N., Havouis, R., Nick, H., Pierre, J., Brissot, P., & Lescoat, G. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.001 · Cited by 51
Sartorelli, A. C., & Booth, B. A. (1967) · PubMed · Cited by 50
Role of melanotransferrin in iron metabolism: studies using targeted gene disruption in vivo
Sekyere, E. O., Dunn, L., Rahmanto, Y. S., & Richardson, D. R. (2005) · Blood · doi:10.1182/blood-2005-10-4174 · Cited by 50
Self-citationRahmanto, Y. S., Dunn, L., & Richardson, D. R. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm096 · Cited by 48
Self-citationIron Chelators Inhibit VCAM-1 Expression in Human Dermal Microvascular Endothelial Cells
Koo, S., Casper, K. A., Otto, K. B., Gira, A. K., & Swerlick, R. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12144.x · Cited by 42
Cited by
Molecular mechanisms of ferroptosis and its role in cancer therapy
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., & Wang, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14511 · Cited by 639
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
The multifaceted functions of sirtuins in cancer
Chalkiadaki, A., & Guarente, L. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3985 · Cited by 496
Iron Homeostasis and the Inflammatory Response
Wessling-Resnick, M. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104804 · Cited by 480
Lipocalin 2: an emerging player in iron homeostasis and inflammation
Xiao, X., Yeoh, B. S., & Vijay-Kumar, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064559 · Cited by 426
Metadata
- Authors
- Richardson, D. R., Kalinowski, D. S., Lau, S., Jansson, P. J., & Lovejoy, D. B.
- Venue
- Biochimica et Biophysica Acta (BBA) - General Subjects
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 1790
- Issue
- 7
- Pages
- 702-717
- ISSN
- 0304-4165 (ISSN-L)
- OpenAlex
- W2028239350
- Cited by
- 258
- References
- 231
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.